bioRxivNeurosciencePreprint
The value of non-motor features and genetic variants of Parkinson's disease for clustering Lewy body diseases
Olaia Lucas‐JiméneziD, Ibai Palacio DieziD, Natalia OjedaiD, Naroa Ibarretxe‐BilbaoiD, Javier PeñaiD, Beatriz TijeroiD, Marta GaldósiD, Ane Murueta‐GoyenaiD, Rocío Del PinoiD, Marian Acera, Juan Carlos Gómez‐EstebaniD, Iñigo GabilondoiD
Abstract
IntroductionThe use of non-motor Parkinsons disease (PD) features and genetic PD variants for clustering analyses may refine the phenotypic classification of idiopathic Lewy body (LB) diseases. MethodsOne-hundred participants [n=7 E46K-SNCA (n=5 symptomatic and n=2 asymptomatic), n=4 PARK2, n=3 LRRK2, n=8 dementia with Lewy bodies (DLB), n=48 idiopathic PD (iPD), n=30 healthy controls (HC)] underwent a comprehensive evaluation of non-motor and motor PD features. Non-motor features were used to perform a hierarchical clustering analysis with patients and HC using a Scikit-learn toolkit. ResultsClustering analysis suggested three clusters of subjects including Cluster 1 or "Normal-to-mild": young iPD (60 years) classified together with the lowest symptomatic E46K-SNCA, PARK2 carriers and HCs, characterizing by having mild-to-moderate cognitive and motor disabilities with few axial symptoms; and Cluster 3 or "Severe": old iPD (>60 years) classified together with all DLB and the most symptomatic E46K-SNCA carriers, characterized by having severe pattern-specific cognitive disabilities (visual attention, perception, processing speed, memory and executive functions) and severe motor PD manifestations with marked axial symptoms. ConclusionsOur study supports the potential value of incorporating genetic PD variants in data-driven iPD classification algorithms and the usefulness of non-motor PD features, especially visual cognition abnormalities, to facilitate the identification of aggressive LB diseases.
- organism: human
- assay: bulk RNA-seq
- research focus: clustering
- research focus: differential expression
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Universal latent axes capturing Parkinson's patient deep phenotypic variation reveals patients with a high genetic risk for Alzheimer's disease are more likely to develop a more aggressive form of Parkinson's.
Cynthia Sandor, Stephanie Millin, … Caleb Webber·bioRxiv·Feb 18, 2021
- Genetic modifiers of risk and age at onset in GBA associated Parkinson disease and Lewy body dementia
Cornelis Blauwendraat, Xylena Reed, … Andrew Singleton·BrainPeer-reviewed·Oct 23, 2019
- Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease
Alejandro Martínez-Carrasco, Raquel Real, … Huw R. Morris·npj Parkinson s DiseasePeer-reviewed·Aug 31, 2023
- Genetic characterization of Parkinsons Disease in a Chilean cohort
Paula Saffie Awad, Peter Wild Crea, … Pedro Chaná‐Cuevas·medRxiv·Aug 6, 2026
- Whole-genome sequencing of 197 cases with Parkinson's Disease reveals novel pathogenic variants in the Indian population
Hiba Ali, Banashree Mondal, … Shweta Ramdas·npj Parkinson s DiseasePeer-reviewed·Jul 6, 2026
- An improved polygenic score for Parkinson's disease partly explains variable penetrance of genetic Parkinson's disease
Sebastian Sendel, Zied Landoulsi, … Amke Caliebe·medRxiv·Feb 28, 2025